Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]
Latest Information Update: 21 May 2025
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Registrational
- Acronyms PSMA-SRT
Most Recent Events
- 13 May 2025 Planned End Date changed from 12 Jul 2025 to 12 Jul 2027.
- 13 May 2025 Planned primary completion date changed from 12 Jul 2025 to 12 Jul 2026.
- 05 Aug 2024 Planned primary completion date changed from 12 Jul 2024 to 12 Jul 2025.